You have successfully logged out.

Hello !

No content results match your keyword.


    No product results match your keyword.


      Thursday, 17 August 2023

      B. Braun SE: Ingrun Alsleben appointed to the Executive Board

      At its meeting yesterday, the Supervisory Board of B. Braun SE has appointed Mrs. Ingrun Alsleben as member of the Executive Board of B. Braun SE effective January 1, 2024. Mrs. Alsleben comes from the Bayer Group, where she was most recently responsible for the countries Turkey/Iran as CEO and CFO. As of April 1, 2024, Ingrun Alsleben is to take over the position of Chief Financial Officer from Dr. Annette Beller, who will retire.

      Dr. Annette Beller (left) and Ingrun Alsleben (right)